indazoles has been researched along with Leukemia, T-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, G; Chang, S; Chen, G; Dai, B; Gao, L; Hu, L; Li, B; Shi, J; Sun, X; Xiao, W; Xie, B; Xie, Y; Xu, Z; Yu, D; Zhang, Y; Zhu, W | 1 |
| Delaney, S; Feeley, M; Lobreau, AU; Raaphorst, GP; Szekely, JG | 1 |
2 other study(ies) available for indazoles and Leukemia, T-Cell
| Article | Year |
|---|---|
Pterostilbene Induces Cell Apoptosis and Cell Cycle Arrest in T-Cell Leukemia/Lymphoma by Suppressing the ERK1/2 Pathway.
Topics: Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Humans; Indazoles; Jurkat Cells; Leukemia, T-Cell; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Phosphorylation; Piperazines; Reactive Oxygen Species; Stilbenes | 2017 |
Morphological effects of lonidamine on two human-tumor cell culture lines.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Glioma; Humans; Indazoles; Leukemia, T-Cell; Microscopy, Electron; Microscopy, Electron, Scanning; Organelles; Pyrazoles; Tumor Cells, Cultured | 1989 |